Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710177 · ClinicalTrials.gov registry record
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
A clinical trial of Persistent Pulmonary Hypertension of the Newborn, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00710177 is a study of Persistent Pulmonary Hypertension of the Newborn that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00710177, a study of Persistent Pulmonary Hypertension of the Newborn, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if normally occurring variations in a specific gene called PTGS-1 are associated with an increased risk of narrowing of the ductus arteriosus from exposure to over-the-counter pain medicines (NSAIDs).
Conditions Studied
Study Locations (1)
Wisconsin
- Children's Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-01 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00710177
The ClinicalTrials.gov registry entry for NCT00710177 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Pulmonary Hypertension of the Newborn appearing as the primary indexed condition, and to 0 interventions.
NCT00710177 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00710177 about?
NCT00710177 is a clinical study titled "PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn". The purpose of this study is to determine if normally occurring variations in a specific gene called PTGS-1 are associated with an increased risk of narrowing of the ductus arteriosus from exposure to over-the-counter pain medicines (NSAIDs).
What is the current status of trial NCT00710177?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2006-01. Estimated completion is 2028-12.
What conditions does trial NCT00710177 study?
This clinical trial studies the following conditions: Persistent Pulmonary Hypertension of the Newborn.
Who is sponsoring clinical trial NCT00710177?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00710177 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Pulmonary Hypertension of the Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.